After the consultation phase, an updated version of the S3 guideline "Long-term use of opioids in chronic non-tumor-related pain (LONTS)" has been published in mid-April 2020. Representatives of 30 specialist societies and organizations, including two patient self-help organizations, worked on an update of the guideline under the leadership of the German Pain Society.
In Germany, around 70% of opioid prescriptions are for chronic non-tumor-related pain. In about 1% of the German population, opioids for this type of pain are prescribed for the long term, i.e., with at least three prescriptions a year.
The updated guideline has defined evidence-based and consensus-based potential indications, but also contraindications for opioids in chronic non-tumor-related pain.
Also, the authors point out the need for a priori defined therapy goals, list indications for the termination of opioid therapy, and recommend making attempts to reduce or discontinue treatment.
The updated guideline in German can be found here
to our newsletter delivered every second week not to miss important reimbursement information.